GT90001

· Suzhou Kintor Pharmaceutical Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GT90001, covering 2024-02-09 to 2024-02-22. Get the full timeline:

Most recent: Clinical Trial Update: GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma [Phase 2]